INO Archives - Page 4 of 10 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: FCEL, AQXP Recaps & More

Aquanox Pharmaceuticals, Inc. AQXP

AQXP was among the stocks that we presented in yesterday’s premarket report, as we were catching it a couple of days after some really positive developments were announced by the company. Despite already being up significantly at that point, our instincts to include it in our daily interests proved to be well-founded.

The stock made a monstrous move right out of the starting gate from 17.56-55.75, a walloping 217% initial rip, followed by an extreme pullback. The activity in AQXP was so abnormally volatile that trading was temporarily halted. AQXP stock is presently gapping up in premarket trading as high as 38.74 so far this morning.

Familiar Bottom-Bouncers

Yesterday was an interesting session in that we noticed an unusually high number of stocks with which we are very familiar, making some excellent moves off of their recently-attained low-points.

FuelCell Energy, Inc. FCEL – FCEL had been on a continuous backslide for many weeks. The company released a positive PR (Link Below) and things took off from there, as you can see on the included chart. We’ll be looking for the stock to maintain at least half of the advance it made yesterday on any pullbacks.

FuelCell Energy Announces Additional Fuel Cell Sales to South Korean Partner and Highlights Asian Manufacturing (Mon, Aug 10)

___

Inovio Pharmaceuticals, Inc. INO

INO also had a big day generated by a PR. The company entered into a partnership with AstraZeneca to provide its cancer treatment in a deal that could reportedly bring as much as $700M in revenue INO’s way. (>>>Get More Details). We are well-acquainted with this stock, having last mentioned it just a couple of weeks ago. We’ll be keen to track the ensuing activity after yesterday’s major revelation, and roughly 30% increase on the day.

___

Other stocks that we routinely discuss that also made appreciable moves off of relative lows yesterday were Voltari Corp. VLTC, Dominovas Energy Corp. DNRG, and Ascent Solar Technologies, Inc. ASTI. Those familiar bottom-bouncers were joined by New Source Energy Partners. NSLP, a newcomer to our reports. We’ll be watching the whole lot as the week progresses. Continued gains, as well as possible dip-and-rip scenarios could be in the cards for any and/or all of them!

Fresh Options Ideas

We’ve got a nice selection of new options-trading possibilities to enter into the mix today:

Shake Shack, Inc. SHAK – Shake Shack beat on earnings yesterday and is gapping up in the premarket today. As a result we are going to be taking a look at Weekly $72-76 Calls for potential chances at intraday/intraweek flips.

Apple, Inc. AAPL – We’ve had a lot of success with AAPL Options in both the distant and recent past, and a new, longer-term idea to monitor in coming weeks is going to be the Sept. 18th $120-122 Calls.

Twitter, Inc. TWTR – For a prospective idea in the TWTR chain, we’ll stretch our target period out to that same Sept. 18th expiration, and track the 9/18 TWTR $30-32 Calls.

Blue Horseshoe Stocks: SOPW News, PTN on Bottom Watch

Solar Power, Inc. SOPW

SOPW is the first of a couple of news plays that we’re going to be taking a look at this morning. The company has announced the initiation of a 6-month long share repurchase program wherein it will obtain up to $50M of its common stock from the open market.

Xiaofeng Peng, Chairman of SPI stated, “The implementation of our share repurchase program reflects the confidence that our Board and management have in SPI’s growth prospects and our commitment to enhance value for our shareholders while retaining adequate flexibility for future growth.” >>> READ FULL PR

In addition to the favorable PR that, in and of itself would be enough to gain our attention, SOPW has also been searching for a bottom over the past few weeks, and we’ll want to be hanging around when it finds one, as the subsequent rebound could be considerable.

Palatin Technologies, Inc. PTN

PTN has capitalized on the FDA’s recommendation for the first ever treatment for a disorder that affects the female sex drive. The company itself has a similar treatment that is currently enrolling women for Phase-3 trials.

As a result of this heightened attention, this morning, the stock is gapping up over 50% in the premarket. We’re going to tag it for observation, because the potential for a dip-and-rip in situations like these is ever-present.

Palatin Supports FDA Advisory Committee’s Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder (Thu, Jun 4)

LinkedIn Corp. LNKD – Options

Our LNKD Weekly Options Calls that we brought into the mix on Wednesday continued to pay dividends for the second consecutive session yesterday. We wanted to give a quick update on the ranges and total gains that have been possible with those contracts over a two-day span:

$205′s – Range: 6.00-11.64 – Max Gain: 94%
$207.50′s – Range: 4.20-9.29 – Max Gain: 119%
$210′s – Range: 2.60-7.30 – Max Gain: 181%
$212.50′s – Range: 1.58-5.10 – Max Gain: 223%

We want to extend our congratulations to anyone who joined us in taking advantage of the trend in LNKD this week. It wasn’t the first time we’ve made successful options calls on this stock, and it probably won’t be the last.

Extended Watchlist:
ICLD, INO, JDST, OCLS

Blue Horseshoe Stocks: Winning TSLA Calls, VGGL Recap & More

Tesla Motors, Inc. TSLA – Options

On Friday we mentioned some longer-term options-trading ideas for TSLA Calls, and it didn’t take more than a couple trading days for them to bear fruit.

As our regular readers are aware by now, we often like to monitor an entire range of strike prices following a key development, and TSLA’s earnings release last midweek provided the fuel for our success in this case. We pointed to 05/22 $230-240 Calls, and every set of contracts in that range made a sizable run from their lows on Friday to impressive highs during yesterday’s session. Here’s a breakdown of their performances:

$230 Calls – Friday’s Low: 6.85 – Yesterday’s High: 13.50 (Closed: 10.30) – Max Gain: 97%

$232.50 Calls – Friday’s Low: 5.32 – Yesterday’s High: 11.25 (Closed: 8.65) – Max Gain: 111%

$235 Calls – Friday’s Low: 5.96 – Yesterday’s High: 10.60 (Closed: 8.70) – Max Gain: 78%

$237.50 Calls – Friday’s Low: 3.16 – Yesterday’s High: 7.60 (Closed: 5.00) – Max Gain: 140%

$240 Calls – Friday’s Low: 3.84 – Yesterday’s High: 7.50 (Closed: 5.75) – Max Gain: 95%

We are pleased with the progress we’ve seen thus far in these contracts, and we’re interested to see what the next nine trading days will bring leading up to their expiration.

Viggle, Inc. VGGL

Our next order of business this morning is to point out the solid move made by VGGL after we included the stock in yesterday morning’s extended watchlist. Catalyzed by favorable quarterly results (link below), it traded in a range from 3.00 to 4.24; a very respectable intraday move of 41%.

The spike came on roughly 25X the 3-month average volume and VGGL managed to close in the mid-3.70’s, holding the majority of its daily gains. Whenever we see a confluence of these two phenomena, we always want to keep our eyes peeled for a carryover of momentum into subsequent sessions.

52% Year-over-Year Revenue Growth and 116% Increase in Net Registered Users as Viggle Celebrates Its Three-Year Anniversary (Mon, May 11)

Plug Power, Inc. PLUG

Our longer-term subscribers might remember the epic run we tracked in PLUG when we caught the stock coming off its all-time lows near a dime back in 2013. The lowest price we observed following our initiation of coverage on this play was .135 on 02/28/13. It led us on a long and exciting journey to a high of 11.72 nearly a year later, and from then on has held a spot on our list of all-time best calls.

More recently, in 2015, PLUG has been on an overall downtrend that carried the stock to new annual low of 2.32. Yesterday, we observed PLUG coming up off of those lows and hitting a high of 2.65, so we’re going to re-radar this as a potential recovery play. If it can crack through the 50DMA of 2.66, we could be in line to see a more sustained uptrend.

We’ve illustrated the key resistance points on the following chart snapshot:

Extended Watchlist:
THLD, OCN, SPPI, INO, FRO

Blue Horseshoe Stocks: PZOO News, Options & More

Voltari Corp. VLTC

Leading into this week, VLTC had been under consolidation following its epic run to new 52-week highs earlier in April. On Wednesday, the stock ultimately found support at 8.14 and by the time it had reached its daily high yesterday the stock had rebounded back to 11.65, a 43% swing.

VLTC did maintain the majority of its daily gains into the close yesterday. and this morning the stock is gapping up quite substantially with a premarket high of 12.34 already having printed.

There appears to be a key area of resistance around $14, and we’ll want to see VLTC hold support at or above its recent swing low of 8.14 on any pullbacks, in order to keep our interest.

Fresh Options Ideas:

We’ve got a few candidates for potential options trades as we close out the week. Please note that we’re referring to Weekly Calls which are on the cusp of expiration, so these would be for quick-trigger daytrades only. For swing trades into next week, one could look at 05/08 or 05/15 contracts.

Expedia, Inc. EXPE – $97-$99.50 Calls

FireEye, Inc. FEYE – $42-$43.50 Calls

Skyworks Solyutions, Inc. SWKS – $94.50-$96 Calls

Pazoo, Inc. PZOO

We want to touch base with PZOO this morning as we’re noticing a new PR hitting the wires. The stock consolidated for the first time in nearly a month this week, coming down off its recent high of .0204. Yesterday it held a penny as support and, we’ll want to see the stock maintain above that level as the week draws to a close.

TODAY’S NEWS:WHIPPANY, N.J., May 1, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that members of its staff will be attending several investment and marijuana conferences over the month of May. Pazoo is also pleased to announce it will have a booth at the 4th Annual Marijuana Business Conference and Expo, America’s largest national cannabis trade show, being held in Chicago, May 19-21.

With Pazoo’s family of companies about to begin operations, numerous Pazoo representatives will begin attending several upcoming marijuana conferences, with the first one in Chicago, Illinois, followed by a conference in Augusta, Maine. The Home Grown Maine trade show and expo, is New England’s largest and best Medical Marijuana Expo. Due to the greater than anticipated attendance from last year’s show, over 4,000 attendees, expo management changed locations to host this event in a larger facility to accommodate an expected exponential increase in the amount attendees expected for this year’s show…>>> FULL PR

Extended Watchlist:
OCN, JDST, LLNW, KEG, INO

Blue Horseshoe Stocks: PBR, INO, RAD Reviews & More

Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

PBR has continued to perform this week after we caught it coming off its 52-week lows two Thursday’s ag o. At that time one of our main areas of interest was the 05/01 $6.50 Calls, which we subsequently observed trading at a low of .22. This week they’ve attained a high of .71, marking off a tidy 222% move.

The last time we touched upon PBR options on Monday morning, it was in the process of pushing even higher, so we suggested the possibility of rolling up our strike price to both the Weekly and May 1st $7 Calls, and that idea turned out to be a good one as well.

We’ve witnessed a trading range on the Weekly $7’s from .06 -.25, a whopping 316%, while the May 1st $7’s enjoyed an 87% run from .30 to .56.

Inovio Pharmaceuticals, Inc. INO

INO stands among those stocks that we have covered the most over the years. An INO tag search of our archives yields no less than 30 results. We re-flagged it in yesterday’s premarket report and the timing was quite fortuitous.

Yesterday morning the company had announced it had been selected as the leader of a $45M DARPA program to develop practical treatments for the Ebola virus. It fueled a continued rise off of recent lows, and this morning’s news could contribute to that as well. >> READ PR

INO heralded positive results from one of its studies, a DNA-based immunotherapy for the treatment of head and neck cancer. According to the CFO, the “initial data set from Inovio’s first cancer study provides encouraging evidence that we are on an important path to better optimized immunotherapy products.” >> READ PR

We’ll continue to keep watch over INO in the wake of these major developments.

Molycorp, Inc. MCP

MCP started showing up on our scanner back on March 23rd and 24th, when it was trading around .38. It retraced back to its 52-week low of .32 on the 27th.

After reappearing on our extended watchlist yesterday, it has traded as high as .62 in the premarket today; from a low of .484 that’s a 28% move up.

At .62, MCP had shown us a 94% overall move from its ultimate low set just the week before last. With gold and other precious metal prices on the rise again, we’ll continue to track MCP for more potential gain opportunities.

Rite-Aid Corp. RAD

We also wanted to make a quick mention of RAD. We tagged the stock for tracking back on December 4th and on that day we observed the lowest price the stock has traded at since then (5.48).

Since that time the stock has crept (and sometimes leaped) its way up the chart; it broke its 50DMA in early March, and managed break the $9-mark last Thursday, and then again yesterday. At Thursday’s high of 9.07, we had witnessed a total gain of 65%

Wall Street analysts are giving RAD high marks, and the stock is also receiving a 96% Overall “Buy” Rating at BARCHART.COM so we’ll certainly want to keep a close watch on RAD moving forward in the event that it sustains the bullish patterns it has been exhibiting over the past several months.

Extended Watchlist:
EXEL, OPXA, WPCS, MPET, MSTX, SLTD